CORMEDIX INC. - COMMON STOCK
8.9000
04-October-24 15:59:59
15 minutes delayed
Stocks
+0.6100
+7.36%
Today's range
8.2800 - 9.0300
ISIN
N/A
Source
NASDAQ
-
CorMedix Inc. Announces Appointment of Chief Legal Officer
15 Dec 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Partnership With The Leapfrog Group
04 Dec 2023 08:30:00 By Nasdaq GlobeNewswire
-
15 Nov 2023 12:57:47 By Nasdaq GlobeNewswire
-
14 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
02 Nov 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
11 Oct 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
26 Sep 2023 08:30:00 By Nasdaq GlobeNewswire
-
08 Sep 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
06 Sep 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
30 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
-
26 Jul 2023 08:30:00 By Nasdaq GlobeNewswire
-
28 Jun 2023 22:57:02 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
28 Jun 2023 16:07:53 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
21 Jun 2023 08:30:00 By Nasdaq GlobeNewswire
-
15 Jun 2023 08:30:00 By Nasdaq GlobeNewswire
-
Cormedix Inc. To Present At The Jefferies Healthcare Conference
30 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Resubmission of New Drug Application for DefenCath
16 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
15 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
08 May 2023 08:30:00 By Nasdaq GlobeNewswire